p21, ccng1, foxo3b, and fbxw7 contribute to p53-dependent cell cycle arrest

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• The tumor suppressor p53 is crucial for preventing cancer, but its precise mechanisms of action are not fully understood.
• While known targets like PUMA, NOXA, and p21 are involved in apoptosis and cell-cycle arrest, their absence in zebrafish doesn't prevent tumor suppression, indicating other p53 targets exist.

Purpose of the Study:

• To identify novel p53 transcriptional targets involved in tumor suppression, specifically cell-cycle arrest.
• To investigate the role of conserved p53-upregulated genes across species.
• To uncover additional mechanisms of p53-mediated tumor suppression beyond known pathways.

Main Methods:

• Cross-species comparative analysis to identify conserved p53-upregulated genes.
• CRISPR-Cas9 G0 "crispant" screening in quadruple knockout zebrafish (mdm2, puma, noxa, p21).
• Functional analysis of identified genes in p53-dependent cell-cycle arrest.

Main Results:

• Identified 137 conserved p53-upregulated genes, highlighting the importance of ortholog-paralog analysis.
• Demonstrated that p53 can induce cell-cycle arrest independently of p21.
• Discovered ccng1, fbxw7, and foxo3b as novel genes critical for p53-dependent cell-cycle arrest in zebrafish.

Conclusions:

• p53 utilizes multiple transcriptional targets to execute its tumor suppressor functions, including cell-cycle arrest.
• The identified genes (ccng1, fbxw7, foxo3b) represent new players in p53-mediated tumor suppression and offer potential therapeutic targets.
• Cross-species genomic approaches are valuable for uncovering conserved biological mechanisms and novel gene functions.